Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

HOMOLOGOUS BONE MARROW TRANSPLANTATION IN DOGS RECEIVING X RADIATION PLUS URETHANE OR 6-MERCAPTOPURINE

Technical Report ·
OSTI ID:4808380

Studies were made on homologous marrow transplantation in 13 mongrel dogs (Group 1) treated with 6-mercaptopurine (6-MP) or urethan prior to x irradiat-ion (900 r, delivered at a dose rate of 15 r/minute). The marrow dose was 7 to 11 x 10/sup 9/ cells, given on the day following irradiation; urethan (175 or 350 mg/kg) and 6-MP (12.5 or 25 mg/ kg) were administered at 3 or 4 daily intervals during the week prior to irradiation. Mean survival time (MST) in Group 1 was 23 days, with a maximum of 63 days. MST in a group of dogs (Group 2) given homologous marrow after 900 r, but not treated with the chemicals, was 10 days. Group 1 characteristically showed good recovery of peripheral blood granulocyte count by 8 to 10 days, together with objective evidence of marrow take; recovery of mononuclear cell count was not observed, except in the single case which survived for 63 days. None of Group 2 showed any rise in the peripheral blood count after initial depression, and all died with marrow aplasia. Secondary disease in Group 1 was characterized by anorexia weight loss, in- , fection, and lymphoid tissue aplasia in all the animals;, skin atrophy, liver lesions. jaundice, and anemia were seen in some of the animals. The marrow showed active hematopoiesis and moderate to good cellularity in most of Group 1, although megakaryocyte activity was deficient in some. Pneumonia and pulmonary edema were found in many of the dogs, at autopsy. It is evident that the use of these antimetabolites permits the successful transplantation of homologous marrow in dogs at a dose of x radiation (900 r) which, by itself, is insufficient. These compounds (urethan and 6-mercaptopurine) are, therefore, additive to x radiation with respect to suppressing the homograft reaction in dogs. as well as in mice. (auth)

Research Organization:
Naval Radiological Defense Lab., San Francisco
NSA Number:
NSA-16-026869
OSTI ID:
4808380
Report Number(s):
USNRDL-TR-571
Country of Publication:
Country unknown/Code not available
Language:
English

Similar Records

VALUE OF BONE MARROW AND SPLEEN CELL SUSPENSIONS FOR SURVIVAL OF LETHALLY IRRADIATED DOGS
Journal Article · Tue Sep 01 00:00:00 EDT 1959 · Journal of the National Cancer Institute (U.S.) Changed to JNCI, J. Natl. Cancer Inst. · OSTI ID:4236334

TREATMENT OF TOTAL-BODY X-IRRADIATED MONKEYS WITH AUTOLOGOUS AND HOMOLOGOUS BONE MARROW
Journal Article · Sat Jul 01 00:00:00 EDT 1961 · Journal of the National Cancer Institute (U.S.) Changed to JNCI, J. Natl. Cancer Inst. · OSTI ID:4010275

Engraftment of DLA-nonidentical unrelated canine marrow after high-dose fractionated total body irradiation
Journal Article · Wed Mar 31 23:00:00 EST 1982 · Transplantation; (United States) · OSTI ID:6928797